Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
66,729,680
-
Total 13F shares
-
13,346,624
-
Share change
-
+4,673,304
-
Total reported value
-
$24,424,740
-
Put/Call ratio
-
23%
-
Price per share
-
$1.83
-
Number of holders
-
100
-
Value change
-
+$7,463,553
-
Number of buys
-
54
-
Number of sells
-
32
Institutional Holders of INOVIO PHARMACEUTICALS, INC. - Common Stock (INO) as of Q4 2024
As of 31 Dec 2024,
INOVIO PHARMACEUTICALS, INC. - Common Stock (INO) was held by
100 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,346,624 shares.
The largest 10 holders included
Deep Track Capital, LP, BlackRock, Inc., VANGUARD GROUP INC, Stonepine Capital Management, LLC, AIGH Capital Management LLC, BANK OF AMERICA CORP /DE/, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, and GOLDMAN SACHS GROUP INC.
This page lists
100
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.